Ariel Johnson

A leader in healthcare, Ariel Johnson brings together a wealth of experience across investor relations, strategy and marketing as she rejoins the Endotronix team in the role of Vice President of Strategy and Investor Relations. Most recently, Ariel served as the Vice President of Advanced Research and Data Analytics at UnitedHealth Group Research & Development and was responsible for leading teams in determining and communicating investment strategies to drive innovation and paradigm shifts in healthcare. Prior to that she held marketing roles at Endotronix with escalating responsibility, culminating in Director of Marketing. Prior to that she was an Equity Research Analyst for Piper Jaffray (now Piper Sandler) in medical devices and large-cap pharma. Having worked as an equities analyst, Ariel provided sell-side research coverage of the small-, mid- and large-cap medical device and large-cap pharma sectors and formed lasting relationships with the medical device investment community.

Dr. Johnson has a Ph.D. in Oral Biology from the University of Illinois at Chicago, a M.S. in Chemistry from the University of Minnesota and a B.S. and B.A. in Chemistry, Biology and Physiology from the University of Minnesota.